MAPK1 and acute lymphoblastic leukemia: The four main active compounds of MCE involved in the treatment of enteritis are SAN, CHE, PRO, and ALL, and the five core targets are HSP90AA1, MAPK1, HRAS, JAK2, and AKT1.